DistantNews
Support us
New research offers hope for halting pancreatic cancer before it starts
🇬🇷 Greece /Health & Science

New research offers hope for halting pancreatic cancer before it starts

From Ta Nea · () Greek

Translated from Greek, summarized and contextualized by DistantNews.

At a glance

News Sources not specified Context piece
  • Researchers have developed a promising new approach to halt pancreatic cancer before it develops, using experimental drugs to eliminate precancerous cells.
  • A preclinical study in mice showed that this experimental therapy nearly doubled survival rates in pancreatic adenocarcinoma models when administered before cancer appeared.
  • This research, published in Science, supports the emerging field of cancer interception and could revolutionize pancreatic cancer treatment, which currently has a poor prognosis.

A new preclinical study offers hope for intercepting pancreatic cancer before it takes hold, potentially transforming treatment for a disease with a grim outlook. Researchers at the University of Pennsylvania's Perelman School of Medicine and Penn Medicine's Abramson Cancer Center have demonstrated that experimental drugs targeting the KRAS gene can eliminate precancerous lesions in the pancreas.

I am convinced that cancer interception will be the next major frontier in cancer therapy.

— Robert VonderheideDirector of the Abramson Cancer Center, commenting on the potential of cancer interception.

Published in the journal Science, the study showed that this approach nearly doubled survival rates in mouse models of pancreatic adenocarcinoma (PDAC) when the therapy was given before cancer emerged. This marks the first evidence that a drug treatment can halt the development of precancerous pancreatic lesions, strongly supporting the burgeoning field of "cancer interception."

Pancreatic cancer continues to have an extremely poor prognosis, limited treatment options, and no proven prevention or screening strategy. If we can intercept it, meaning identify and neutralize abnormalities in the earliest stages of their malignant evolution, it will be a game-changer.

— Robert VonderheideDirector of the Abramson Cancer Center, explaining the significance of intercepting pancreatic cancer.

"I am convinced that cancer interception will be the next major frontier in cancer therapy," said Robert Vonderheide, director of the Abramson Cancer Center. "Pancreatic cancer continues to have an extremely poor prognosis, limited treatment options, and no proven prevention or screening strategy. If we can intercept it, meaning identify and neutralize abnormalities in the earliest stages of their malignant evolution, it will be a game-changer."

This study offers preclinical proof that cancer interception works better than treatment after diagnosis.

— Min TanLead author of the study, commenting on the findings.

Cancer interception differs from traditional prevention methods like HPV vaccination or smoking cessation. Instead, it focuses on the initial steps that lead a cell toward cancerous transformation. The study utilized two experimental drugs that target the KRAS gene, which is implicated in over 90% of pancreatic cancer cases. The research highlights the power of proactive intervention over treating the disease after it has manifested.

The research highlights the power of proactive intervention over treating the disease after it has manifested.

— Min TanLead author of the study, emphasizing the importance of early intervention.
DistantNews Editorial

Originally published by Ta Nea in Greek. Translated, summarized, and contextualized by our editorial team with added local perspective. Read our editorial standards.

More Stories

From Our Blog